According to Cognitive Market Research, the global Antifungal Drugs market size was USD 16241.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 6496.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 4872.36 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 3735.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 812.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 324.82 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
The fastest-growing segment is Echinocandins, driven by rising fungal infections.
